logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – 2 month improvement seen in median overall survival for patients with heavily pretreated metastatic gastric cancer receiving trifluridine/tipiracil

In the TAGS trial, preventing the degradation of the thymidine analog trifluridine prolonged overall survival in metastatic gastric cancer.